Keyword: Merck Sharp %26 Dohme

News

DCAT Announces New Board of Directors

02.11.2018 - Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...

News

Lilly-backed Study Confirms Evacetrapib Fail

05.04.2016 - Results from the just-concluded studies of the Eli Lilly drug candidate evacetrapib by the Cleveland Clinic in Ohio, USA, have underscored other findings that industry watchers...

News

US Gives Merck’s Antitoxin Priority Review

02.02.2016 - The US Food and Drug Administration (FDA) has granted priority review to US drug maker Merck & Co for bezlotoxumab, an antitoxin for preventing the recurrence of Clostridium...

News

NICE Approves Two Biosimilars for Arthritis

02.02.2016 - Rheumatoid arthritis sufferers in England will soon be able to benefit from a cheaper generic version of US pharmaceutical producer Merck’s and the world’s best-selling medicines...

News

GAVI and US Merck Link on Ebola Vaccine

27.01.2016 - Geneva, Switzerland-based GAVI (Global Alliance for Vaccines and Immunization), a public-private partnership, and Merck Sharp & Dohme (MSD), known in the US as Merck & Co, have...